iNO
Sponsors
University of Colorado, Denver, Emory University, University of Oklahoma, Duke University, Bellerophon Pulse Technologies
Conditions
Acute Cerebrovascular DiseaseBronchopulmonary DysplasiaCerebrovascular DisordersHeart Transplant SurgeryLung DiseasesLung Transplant SurgeryPulmonary Arterial HypertensionPulmonary Fibrosis
Phase 1
Phase 2
Phase 3
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
CompletedNCT00006401
Start: 2000-09-30End: 2007-10-31Target: 793Updated: 2015-10-06
Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric
WithdrawnNCT03602781
Start: 2018-08-31End: 2020-06-30Updated: 2023-02-21
Phase 4
Unknown Phase
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
CompletedNCT00139217
Start: 2005-08-31End: 2007-09-30Target: 400Updated: 2014-05-29
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
CompletedNCT01220687
Start: 2011-04-30End: 2017-05-01Updated: 2020-08-19